South Australian researchers are working to improve outcomes for skin cancer patients after discovering a particular protein may determine the fate of people with the disease.
A team from the University of South Australia's Centre for Cancer Biology has identified the desmoglein-2 (DSG-2) protein and found melanoma patients who express it are two-and-a-half times more likely to die within 10 years.
